{"id":13774,"date":"2026-09-19T16:40:10","date_gmt":"2026-09-19T16:40:10","guid":{"rendered":"https:\/\/www.lifescienceart.com\/?p=13774"},"modified":"2026-09-19T16:40:10","modified_gmt":"2026-09-19T16:40:10","slug":"personalized-mrna-vaccine-shows-promise-against-melanoma","status":"publish","type":"post","link":"https:\/\/www.lifescienceart.com\/cs\/science\/medicine\/personalized-mrna-vaccine-shows-promise-against-melanoma\/","title":{"rendered":"Personalizovan\u00e1 mRNA vakc\u00edna proti melanomu \u2013 pr\u016flomov\u00e9 v\u00fdsledky klinick\u00e9 f\u00e1ze\u202f2"},"content":{"rendered":"

Personalizovan\u00e1 mRNA vakc\u00edna ukazuje slibn\u00e9 v\u00fdsledky proti melanomu<\/h2>\n\n

Pozad\u00ed<\/h2>\n\n

Melanom je nejnebezpe\u010dn\u011bj\u0161\u00ed typ ko\u017en\u00edho karcinomu a p\u0159edstavuje v\u011bt\u0161inu \u00famrt\u00ed na tuto nemoc. Tradi\u010dn\u00ed l\u00e9\u010dby melanomu zahrnuj\u00ed chirurgii, chemoterapii a radioterapii. Tyto l\u00e9\u010dby v\u0161ak mohou m\u00edt v\u00fdznamn\u00e9 vedlej\u0161\u00ed \u00fa\u010dinky a nejsou v\u017edy \u00fa\u010dinn\u00e9 v prevenci recidivy.<\/p>\n\n

Technologie mRNA vakc\u00edn<\/h2>\n\n

mRNA vakc\u00edny jsou nov\u00fd typ vakc\u00edny, kter\u00fd ukazuje slibn\u00e9 v\u00fdsledky v prevenci a l\u00e9\u010db\u011b r\u016fzn\u00fdch onemocn\u011bn\u00ed, v\u010detn\u011b rakoviny. mRNA vakc\u00edny funguj\u00ed tak, \u017ee do bun\u011bk v t\u011ble doprav\u00ed messenger RNA (mRNA), kter\u00e1 pak bu\u0148ky instruuje vyr\u00e1b\u011bt proteiny, je\u017e spou\u0161t\u011bj\u00ed imunitn\u00ed reakci.<\/p>\n\n

Personalizovan\u00e1 mRNA vakc\u00edna pro melanom<\/h2>\n\n

V\u00fdzkumn\u00edci vyvinuli personalizovanou mRNA vakc\u00ednu pro melanom, kter\u00e1 je p\u0159izp\u016fsobena ka\u017ed\u00e9mu jednotliv\u00e9mu pacientovi. Vakc\u00edna se vytv\u00e1\u0159\u00ed pomoc\u00ed n\u00e1dorov\u00fdch bun\u011bk odebran\u00fdch od pacienta b\u011bhem operace. Tyto n\u00e1dorov\u00e9 bu\u0148ky jsou n\u00e1sledn\u011b analyzov\u00e1ny za \u00fa\u010delem identifikace unik\u00e1tn\u00edch neoantigen\u016f, kter\u00e9 se nach\u00e1zej\u00ed na jejich povrchu. Neoantigeny jsou proteiny, kter\u00e9 jsou p\u0159\u00edtomny v n\u00e1dorov\u00fdch bu\u0148k\u00e1ch, ale ne v zdrav\u00fdch bu\u0148k\u00e1ch.<\/p>\n\n

Personalizovan\u00e1 mRNA vakc\u00edna je navr\u017eena tak, aby nau\u010dila imunitn\u00ed syst\u00e9m pacienta rozpozn\u00e1vat a \u00fato\u010dit na tyto neoantigeny. Zam\u011b\u0159en\u00edm se na v\u00edce neoantigen\u016f m\u016f\u017ee vakc\u00edna stimulovat siln\u011bj\u0161\u00ed a \u00fa\u010dinn\u011bj\u0161\u00ed imunitn\u00ed reakci.<\/p>\n\n

V\u00fdsledky studie f\u00e1ze 2<\/h2>\n\n

Studie f\u00e1ze 2 personalizovan\u00e9 mRNA vakc\u00edny pro melanom byla ned\u00e1vno provedena a v\u00fdsledky byly p\u0159edstaveny na setk\u00e1n\u00ed American Association for Cancer Research (AACR). Studie zahrnovala 157 pacient\u016f s vysokorizikov\u00fdm melanomem, kte\u0159\u00ed podstoupili chirurgick\u00e9 odstran\u011bn\u00ed n\u00e1doru.<\/p>\n\n

Pacienti byli randomizov\u00e1ni bu\u010f k pod\u00e1n\u00ed personalizovan\u00e9 mRNA vakc\u00edny v kombinaci s imunoterapeutikem Keytruda, nebo jen Keytruda. V\u00fdsledky uk\u00e1zaly, \u017ee kombinace vakc\u00edny a Keytruda byla podstatn\u011b \u00fa\u010dinn\u011bj\u0161\u00ed v prevenci recidivy ne\u017e samotn\u00e9 Keytruda.<\/p>\n\n

Konkr\u00e9tn\u011b b\u011bhem dvou let se rakovina vr\u00e1tila u 40\u202f% pacient\u016f, kte\u0159\u00ed dost\u00e1vali jen Keytruda. U t\u011bch, kte\u0159\u00ed dost\u00e1vali oba p\u0159\u00edpravky, byla m\u00edra recidivy pouze 22\u202f%. To znamen\u00e1, \u017ee pou\u017eit\u00ed vakc\u00edny sn\u00ed\u017eilo riziko recidivy nebo \u00famrt\u00ed o 44\u202f% ve srovn\u00e1n\u00ed s l\u00e9\u010dbou pouze Keytrudou.<\/p>\n\n

V\u00fdznam zji\u0161t\u011bn\u00ed<\/h2>\n\n

V\u00fdsledky t\u00e9to studie f\u00e1ze 2 jsou velmi slibn\u00e9 a nazna\u010duj\u00ed, \u017ee personalizovan\u00e1 mRNA vakc\u00edna by mohla p\u0159edstavovat pr\u016flom v l\u00e9\u010db\u011b melanomu. Vakc\u00edna je dob\u0159e tolerov\u00e1na a m\u00e1 potenci\u00e1l v\u00fdrazn\u011b zlep\u0161it v\u00fdsledky u pacient\u016f s touto smrtelnou nemoc\u00ed.<\/p>\n\n

Dal\u0161\u00ed kroky<\/h2>\n\n

V\u00fdzkumn\u00edci v sou\u010dasn\u00e9 dob\u011b pl\u00e1nuj\u00ed studii f\u00e1ze 3 personalizovan\u00e9 mRNA vakc\u00edny pro melanom. Tato studie bude zahrnovat v\u011bt\u0161\u00ed po\u010det pacient\u016f a d\u00e1le bude hodnotit bezpe\u010dnost a \u00fa\u010dinnost vakc\u00edny. Pokud bude studie f\u00e1ze 3 \u00fasp\u011b\u0161n\u00e1, vakc\u00edna by mohla b\u00fdt schv\u00e1lena k pou\u017eit\u00ed b\u011bhem t\u0159\u00ed let.<\/p>\n\n

Z\u00e1v\u011br<\/h2>\n\n

V\u00fdvoj personalizovan\u00e9 mRNA vakc\u00edny pro melanom p\u0159edstavuje v\u00fdznamn\u00fd pokrok v boji proti t\u00e9to smrt\u00edc\u00ed nemoci. Vakc\u00edna uk\u00e1zala slibn\u00e9 v\u00fdsledky v ran\u00fdch klinick\u00fdch studi\u00edch a v\u00fdzkumn\u00edci doufaj\u00ed, \u017ee bude nakonec schv\u00e1lena k pou\u017eit\u00ed u pacient\u016f.<\/p>","protected":false},"excerpt":{"rendered":"

Personalizovan\u00e1 mRNA vakc\u00edna ukazuje slibn\u00e9 v\u00fdsledky proti melanomu Pozad\u00ed Melanom je nejnebezpe\u010dn\u011bj\u0161\u00ed typ ko\u017en\u00edho karcinomu a p\u0159edstavuje v\u011bt\u0161inu \u00famrt\u00ed na tuto nemoc. Tradi\u010dn\u00ed l\u00e9\u010dby melanomu zahrnuj\u00ed chirurgii, chemoterapii a radioterapii.…<\/p>\n","protected":false},"author":2,"featured_media":25597,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[359],"tags":[18523,18526,3368,18522,18524,18525,18527,5613],"class_list":["post-13774","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicine","tag-cancer-vaccine","tag-clinical-trial","tag-immunotherapy","tag-melanoma","tag-mrna-vaccine","tag-personalized-medicine","tag-phase-2-trial","tag-cancer-research"],"_links":{"self":[{"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/posts\/13774","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/comments?post=13774"}],"version-history":[{"count":2,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/posts\/13774\/revisions"}],"predecessor-version":[{"id":25598,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/posts\/13774\/revisions\/25598"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/media\/25597"}],"wp:attachment":[{"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/media?parent=13774"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/categories?post=13774"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.lifescienceart.com\/cs\/wp-json\/wp\/v2\/tags?post=13774"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}